Growing occurrence of bacterial infections is expected to drive the growth of India potassium clavulanate market during the forecast period.
According to TechSci Research report, “India Potassium Clavulanate Market By Composition (Single, Combinational), By Route of Administration (Oral v/s Intravenous), By Form (Tablet, Capsule, Syrup, Injection), By Distribution Channel (Online v/s Offline), By Source (In-house v/s Contract Manufacturing Organizations), By Application (Respiratory Tract Infections, Skin Infections, UTI, Otitis media, Gynaecological infections, Bone and Joint Infections and Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026”, the India potassium clavulanate market is expected to grow at a steady pace during the forecast period. This drug is a beta-lactamase inhibitor which is commonly used in combination with other antibiotics such as amoxicillin, cefixime, and cefpodoxime in order to fight the antibiotic resistance. Potassium clavulanate is available in both generic and brand versions. High mortality rate associated with community-acquired pneumonia is one of the major factors which is expected to fuel the market growth through FY2026. However, side effects caused due to drug consumption including diarrhea, nausea, vomiting, headache, skin rash or itching, can restrict the market growth over the next few years. Lack of awareness about the onset and risks of bacterial infections among the population might act as a major impediments to the market growth in the coming years.
TABLE 1: Newer Antibiotics Used in Skin and Soft Tissue Infections
MECHANISM OF ACTION
2nd generation Cefprozil
Inhibits bacterial cell wall synthesis
Inhibits bacterial cell wall synthesis by binding penicillin-binding proteins.
Inhibition of RNA-dependent protein synthesis by binding to 50S subunit of 70S ribosome.
Inhibition of bacterial DNA gyrase
Inhibits biosynthesis of peptidoglycans.
Source: IJDVL (Indian Journal of Dermatology, Venereology and Leprology)
Browse XX market data Tables and XX Figures spread throughXXX Pages and an in-depth TOC on“India Potassium Clavulanate Market”
The India potassium clavulanate market is segmented based on composition, route of administration, form, distribution channel, source, application, end user, company, and region. Based on source, the market can be categorized into in-house v/s contract manufacturing organizations. The in-house segment dominated the market until FY2020 as majority of the key market players prefer in house production owing to the reduced dependency on suppliers. Additionally, in-house production can provide fast and flexible response to market changes which is further expected to contribute to the segmental growth during the forecast period. Based on end user, the market can be fragmented into adult v/s pediatric. Adult end user segment dominated the market until FY2020 and is expected to maintain its dominance in the market during forecasted years as well on account of high incidence of bacterial infections in adults.
MacLeod’s Pharmaceuticals Ltd.., Hetero Healthcare Ltd., HLL Lifecare Ltd., Novartis India Ltd. (Sandoz), Modi Mundipharma Ltd., Ikon Remedies Pvt. Ltd., Glenmark Pharmaceuticals Ltd., Elkos Healthcare Pvt. Ltd., Lupin Laboratories Ltd., Zee Laboratories Ltd. and others are some of the leading players operating in India potassium clavulanate market. Companies operating in the market are using organic strategies such as product launches, mergers and acquisitions and research collaborations to boost their share and increase their geographic reach.
Customers can also request for 10% free customization on this report.
“India potassium clavulanate market is expected to witness growth in the next 5 years which can be attributed to the popularity of this drug among the individuals for treatment of pyelonephritis caused by gram-positive bacteria. In addition to this, increased count of skin and tissue infections amongst population including cellulitis, animal bites, severe dental abscess, etc. is further expected to create lucrative opportunities for the market growth of India potassium clavulanate market over the next five years. Rising percentage of geriatrics in the country is forecasted to aid the growth of potassium clavulanate market over the forthcoming years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based India management consulting firm.
“India Potassium Clavulanate Market By Composition (Single, Combinational), By Route of Administration (Oral v/s Intravenous), By Form (Tablet, Capsule, Syrup, Injection), By Distribution Channel (Online v/s Offline), By Source (In-house v/s Contract Manufacturing Organizations), By Application (Respiratory Tract Infections, Skin Infections, UTI, Otitis media, Gynaecological infections, Bone and Joint Infections and Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India potassium clavulanate market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in India potassium clavulanate market.